Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alivus Life Sciences's dividends per share for the
three
months ended in Mar. 2026 was ₹0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.00. Its Dividend Payout Ratio for the
three
months ended in Mar. 2026 was 0.00. As of today, Alivus Life Sciences's Dividend Yield % is 0.44%.
Warning Sign:
Alivus Life Sciences Ltd stock Dividend Yield % is close to 5-year low.
During the past 3 years, the average Dividends Per Share Growth Rate was -45.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of Alivus Life Sciences was -45.90% per year. The lowest was -45.90% per year. And the median was -45.90% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Alivus Life Sciences (NSE:ALIVUS) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Alivus Life Sciences's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 8 years, the highest Dividend Payout Ratio of Alivus Life Sciences was 0.83. The lowest was 0.11. And the median was 0.44.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Alivus Life Sciences Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 5.000000
2025-09-01
2025-09-01
2025-09-12
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Alivus Life Sciences's Dividend Yield (%) for Today is calculated as
Current Share Price is ₹1145.40.
Alivus Life Sciences's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹5.
During the past 8 years, the highest Dividend Yield of Alivus Life Sciences was 8.04%. The lowest was 0.43%. And the median was 2.48%.
Warning Sign:
Alivus Life Sciences Ltd stock Dividend Yield % is close to 5-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alivus Life Sciences Dividends per Share Related Terms
Alivus Life Sciences Dividends per Share Historical Data
* Premium members only.
The historical data trend for Alivus Life Sciences's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ALIVUS vs ZTS, UTHR: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alivus Life Sciences Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Alivus Life Sciences's Dividend Yield % falls into.
Alivus Life Sciences (NSE:ALIVUS) has a Dividends per Share of ₹5.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Alivus Life Sciences and its competitors.
Is Alivus Life Sciences' Dividends per Share too high?
Alivus Life Sciences' current Dividends per Share is ₹5.00. Overall, Alivus Life Sciences has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alivus Life Sciences' Dividends per Share compare to ZTS and UTHR?
Alivus Life Sciences' Dividends per Share of ₹5.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Alivus Life Sciences and its competitors. Alivus Life Sciences's current Dividends per Share is ₹5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alivus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Alivus Life Sciences (NSE:ALIVUS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,009.81, compared to a current price of ₹1,145.40 — trading 13.4% above its estimated fair value. The current Dividends per Share is ₹5.00. Alivus Life Sciences' overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Alivus Life Sciences (NSE:ALIVUS), the current Dividends per Share is ₹5.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alivus Life Sciences (NSE:ALIVUS) Overvalued in 2026?
Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued.
The current stock price of ₹1,145.40 is trading 13.4% above its estimated GF Value™ of ₹1,009.81.
GuruFocus considers Alivus Life Sciences to be Modestly Overvalued.
Key valuation signals for NSE:ALIVUS:
Dividends per Share: ₹5.00
GF Value™: ₹1,009.81 vs. price of ₹1,145.40 (13.4% above fair value)
No single metric tells the full story. See the NSE:ALIVUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
86GF Score
Get the complete analysis for NSE:ALIVUS
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALIVUS has been successfully added to your 
